| Compañía | Compartir, % |
|---|---|
| Chemomab Therapeutics Ltd. | 12.87 |
 BioVie Inc.
|
8.79 |
 Odonate Therapeutics, Inc.
|
5.16 |
 Corbus Pharmaceuticals Holdings, Inc.
|
4.36 |
| Achilles Therapeutics plc | 3.51 |
 Annexon, Inc.
|
3.38 |
| Longboard Pharmaceuticals, Inc. | 2.91 |
| Pyxis Oncology, Inc. | 2.82 |
 Abeona Therapeutics Inc.
|
2.19 |
 Lyra Therapeutics, Inc.
|
2.1 |
 Protara Therapeutics, Inc.
|
1.65 |
 AVROBIO, Inc.
|
1.6 |
 Chiasma, Inc.
|
1.26 |
| InflaRx N.V. | 1.2 |
 ERYTECH Pharma S.A.
|
0.73 |
| AEON Biopharma, Inc. | 0.68 |
| Anebulo Pharmaceuticals, Inc. | 0.62 |
 ProQR Therapeutics N.V.
|
0.58 |
| Tempest Therapeutics, Inc. | 0.55 |
 HOOKIPA Pharma Inc.
|
0.55 |
| Categoría | Cantidad |
|---|---|
| Healthcare | 22 |
